IndraLab

Statements


| 2

reach
"Interestingly, we found that geldanamycin and its analog 17-AAG, which was previously known to inhibit IRF3 activation by RNA viruses, block MAVS aggregation."

reach
"Taken together, these results suggest that geldanamycin and 17-AAG inhibit IRF3 activation by preventing MAVS aggregation on the mitochondria."